Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2471 (LINC02471)
- Target
- LINC02471
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2471 (LINC02471) is a member of the long non-coding RNA family, specifically a lincRNA that does not overlap protein-coding genes[1][3][7]. While the molecular and cellular functions of LINC02471 remain largely uncharacterized, lincRNAs as a class are increasingly recognized for their involvement in gene regulatory mechanisms, including chromatin remodeling, transcriptional control, and epigenetic modulation[3][5]. LINC02471 has been implicated in molecular diagnostic panels for cancer, particularly nonmedullary thyroid and endometrial cancer, but there is no evidence of direct druggability or therapeutic targeting at this time[4][7]. Overall, LINC02471 represents an emerging biomarker candidate with as-yet undefined functional roles in pathology.
- Other names
- AC079630.2LINC02471
02
Biological functions
Potential regulation of gene expression, especially at the transcriptional or epigenetic level as is typical for lincRNAsOther (no function has been directly attributed to LINC02471 specifically in published sources)
03
Disease associations
Cancer (reported associations include nonmedullary thyroid cancer and inclusion in candidate molecular diagnosis panels for cancer subtyping)
04
Biomarkers
LINC02471 is included as a candidate long non-coding RNA in molecular diagnostic panels for endometrial and other cancers, suggesting potential as a biomarker
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2471 (LINC02471).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2471 (LINC02471).